相关实验视频

Updated: Jul 8, 2025

Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons

Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons

Published on: August 26, 2021

缺少ALDH5A1的IPSC衍生激发性和抑制性神经元表现出细胞类型特定的变化

Wardiya Afshar-Saber¹, Nicole A Teaney¹, Kellen D Winden¹

¹Rosamund Stone Zander Translational Neuroscience Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; FM Kirby Neurobiology Center, Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Neurobiology of disease

|December 18, 2023

概括

人类神经元中的半脱酶缺乏症 (SSADHD) 揭示了激发细胞中的新型作用. 在患者衍生的神经元中纠正ALDH5A1突变可以挽救代谢和功能缺陷,提供治疗见解.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
生物化学生物化学

背景情况:

黄半脱酶缺乏症 (SSADHD) 是一种神经代谢疾病,与ALDH5A1突变有关.
它会导致GABA和GHB的积累,影响神经传递,导致自闭症和.
抑制性神经递质积累引发发作的机制尚未完全理解.

研究的目的:

用患者衍生的神经元研究SSADHD的细胞和分子基础.
探索SSADHD在抑制和刺激神经元功能中的作用.
为了确定SSADHD的潜在治疗点.

主要方法:

从SSADHD患者中产生诱导多能干细胞 (iPSC).
将iPSC区分为GABAergic和Glutamatergic的神经元.
对GABA代谢,基因表达和神经元活动的分析.
基于CRISPR的致病变体校正和mRNA救援实验.

主要成果:

SSADHD神经元表现出改变的GABA代谢和抑制神经传递基因表达的变化.
谷氨酸性神经元显示自发活动增加和线粒体基因上调.
克里斯普尔校正和mRNA救援恢复了患者衍生的神经元中的代谢和功能异常.

结论:

SSADHD在人类刺激神经元中起到以前未知的作用.
这些发现为SSADHD的病理生理学提供了洞察力,将其与刺激性神经元功能障碍联系起来.
这项研究强调了通过准代谢和功能缺陷来治疗SSADHD的潜在治疗途径.

关键词:

自闭症谱系障碍自闭症谱系障碍是一种病.GABA代谢的代谢GABA代谢的代谢线粒体中的线粒体.干细胞衍生神经元的神经元.

更多相关视频

Subtype-selective Electroporation of Cortical Interneurons

Subtype-selective Electroporation of Cortical Interneurons

Published on: August 18, 2014

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.